Sign In
Buy MEDIF
$0.0539
-0.0024 (-4.33%)
At Close: Jun 03, 2026
MediPharm is Dangerously Low On Cash and is On Track to Run Out of Money by November Unless Wholesale Change Occurs MediPharm Lost Over $3.3 Million in Q1 2025 While Management Offered No Clear Plan t
MediPharm Labs Raises Concerns About Poorly Qualified Dissident Nominees
07:40am, Thursday, 15'th May 2025
TORONTO , May 15, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today provided its shareho
MediPharm Labs Corp. (MEDIF) Q1 2025 Earnings Call Transcript
01:09pm, Wednesday, 14'th May 2025
MediPharm Labs Corp. (MEDIF Q1 2025 Earnings Conference Call May 14, 2025 10:00 AM ET Company Participants David Pidduck - President & Chief Executive Officer Greg Hunter - Chief Financial Officer Con
Company Has Suspended Calls Since the Second Quarter of 2024 to Avoid Facing the Music for Board's and Management Team's Destruction of 99% of Stock's Value, Costing Shareholders $1 Billion Confere
MediPharm Labs Announces Strong Q1 2025 Results
07:30am, Wednesday, 14'th May 2025
Achieves Positive Adjusted EBITDA(1) Revenue of $10.8 Million, an Increase of 11% over Q1 2024 87% Growth in International Medical Cannabis Revenue, Forming 55% of Total Revenue Gross Profit of $4.2 m
MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results
07:00am, Friday, 09'th May 2025
TORONTO , May 9, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-bas
MediPharm Labs Responds to Dissident Shareholder's Filing
06:35pm, Thursday, 08'th May 2025
TORONTO , May 8, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is aware of the dissident p
Believes Board Change is Urgently Needed: Under the Current Board and Management, MediPharm Stock Price is Down More Than 99%, Costing Shareholders Nearly $1 Billion MediPharm's Board Cannot be Truste
MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results
07:00am, Monday, 31'st Mar 2025
Annual Net Revenue Increase of 27% to $42M, Driven by Record $18M International Medical Cannabis Revenue and Approaching Positive Adjusted EBITDA(1) for Q4. TORONTO , March 31, 2025 /PRNewswire/ - Me
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results
07:00am, Wednesday, 26'th Mar 2025
TORONTO , March 26, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision
MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana Health
07:00am, Monday, 10'th Feb 2025
TORONTO , Feb. 10, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") has terminated the previously announced sale of its facility in
MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health
07:00am, Thursday, 16'th Jan 2025
TORONTO , Jan. 16, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") is pleased to provide an update with respect to the previously
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
07:00am, Wednesday, 08'th Jan 2025
MediPharm Labs expands its Brazilian presence where the medical cannabis market is estimated to be worth $198 million in 2024, serving over 670,000 patients.1 Products include full-spectrum, GMP subli
MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M
07:29am, Tuesday, 17'th Dec 2024
TORONTO , Dec. 17, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") and Kensana Health Inc. ("Kensana Health") are pleased to announ
MediPharm Labs Reports Third Quarter Results
07:00am, Thursday, 14'th Nov 2024
Strong Growth in International GMP Medical Markets TORONTO , Nov. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a
